Recently an Israeli company claimed that they have invented a drug that clear HIV viral load and they claimed that they have done studies on 9 people with HIV. When investigated further this news only came about 2 weeks ago ,a month after BIT's drug trail results.
Link here
https://www.news.com.au/technology/...e/news-story/73337f26a96c8a794ed7bf29e8f21195
Later it was found that the Israeli company did not have any such evidence to prove their claim and it was deemed as 'smacks of quackery".
Link for a read here
https://www.health-e.org.za/2018/11/06/hiv-cure-smacks-of-quackery-scientist/
http://www.aidsmap.com/Gammora-does-not-cure-HIV/page/3363143/
Many discussions and research articles I have researched talks about viral reservoirs and the importance of eradicating virus from macrophages cells----read it twice. That is the prime factor here with BIT.
BIT has been professional and consistent with their claims ,that they have found something new and novel. Director's behavior indicates that they are not doing "smacks of quackery". Ms MM and other directors have converted their options and increased share holdings--a vote of confidence.
CPS Capital undertaking 30 November 18 options --why would they undertake it if they don't see significant value in it? We are talking about millions here.
Recent buys worth millions tells me that its not mum and dad investors who is playing here.
Above all as mentioned in September announcement ,the company got a chair for a presentation within short time frame after the results .
My take is that the world is watching. I am keeping my holdings .Its your judgment anyway..
